EUVIMEDEUVIMED entdecken
Crossref

Biomarker Discovery for Early Diagnosis of Papillary Thyroid Carcinoma Using High-Throughput Enhanced Quantitative Plasma Proteomics

Hongsheng Lu iD, Yin Pan, Yanyun Ruan, Chumeng Zhu, Hozeifa M Hassan, Junshun Gao, Junli Gao, Lilong Fan, Xi Liang, Hong Wang, Shenpeng Ying, Qi Chen iD

Journal of Proteome Research · 2023

DOI: 10.1021/acs.jproteome.3c00187 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Proteome Research, 2023. Verfasst von Hongsheng Lu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Taizhou Central Hospital (Taizhou University Hospital), 999 Donghai Avenue, Taizhou 318000, Zhejiang, P. R. China. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Biomarkers, Tumor, Proteomics, Carcinoma, Papillary. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Science and Technology Department of Zhejiang Province, Science and Technology Plan Project of Taizhou, Department of Health of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The incidence of thyroid cancer (TC) has been increasing over the last 50 years worldwide. A higher rate of overdiagnosis in indolent thyroid lesions has resulted in unnecessary treatment. An accurate detection of TC at an early stage is highly demanded. We aim to develop an enhanced isobaric labeling-based high-throughput plasma quantitative proteomics to identify biomarkers in a discovery cohort. Selected candidates were tested by enzyme-linked immunosorbent assay (ELISA) in the training cohort and validation cohort. In total, 1063 proteins were quantified, and 129 proteins were differentially expressed between patients and healthy subjects. Serum levels of ISG15 and PLXNB2 were significantly elevated in patients with papillary thyroid cancer (PTC) or thyroid adenoma, compared to healthy subjects (p < 0.001) and patients with nodular goiter (p < 0.001). Receiver operating characteristic (ROC) analysis of combined markers (ISG15 and PLXNB2) significantly distinguished PTC from healthy control (HC) subjects. Similar differentiations were also found between thyroid adenoma and HC subjects. Notably, this combined marker could distinguish stage-I PTC from HC subjects (area under the curve (AUC) = 0.872). Our results revealed that ISG15 and PLXNB2 are independent diagnostic biomarkers for PTC and thyroid adenoma, showing a promising value for the early detection of PTC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsBiomarkers, TumorProteomicsCarcinoma, PapillaryHumansThyroid Cancer, PapillaryFemaleMaleMiddle AgedEarly Detection of CancerAdultCytokinesUbiquitinsROC CurveCase-Control StudiesHigh-Throughput Screening AssaysEnzyme-Linked Immunosorbent Assay

Stichwörter der Autor:innen

early diagnosisenhanced quantitative plasma proteomicspapillary thyroid cancerprotein biomarker

Substanzen

Biomarkers, TumorCytokinesISG15 protein, humanUbiquitins

Autor:innen und Institutionen

  • Department of Pathology, Taizhou Central Hospital (Taizhou University Hospital), 999 Donghai Avenue, Taizhou 318000, Zhejiang, P. R. China.
  • Surgical Oncology, Taizhou Central Hospital (Taizhou University Hospital), 999 Donghai Avenue, Taizhou 318000, Zhejiang, P. R. China.
  • Precision Medicine Center, Taizhou Central Hospital (Taizhou University Hospital), 999 Donghai Avenue, Taizhou 318000, Zhejiang, P. R. China.
  • Hangzhou Cosmos Wisdom Mass Spectrometry Center of Zhejiang University Medical School, 198 Qidi Road, Xiaoshan District, Hangzhou 311202, Zhejiang, P. R. China.
  • Key Laboratory of Precision Medicine in Diagnosis and Monitoring Research of Zhejiang Province, 198 Qidi Road, Xiaoshan District, Hangzhou 311202, Zhejiang, P. R. China.
  • Department of Radiotherapy, Taizhou Central Hospital (Taizhou University Hospital), 999 Donghai Avenue, Taizhou 318000, Zhejiang, P. R. China.

ORCID-Profile: Hongsheng Lu, Qi Chen

Förderung

  • Science and Technology Department of Zhejiang Province
  • Science and Technology Plan Project of Taizhou
  • Department of Health of Zhejiang Province
  • Taizhou University Hospital

Zitieren

APA

Lu, H., Pan, Y., Ruan, Y., Zhu, C., Hassan, H. M., Gao, J., Gao, J., Fan, L., Liang, X., Wang, H., Ying, S., & Chen, Q. (2023). Biomarker Discovery for Early Diagnosis of Papillary Thyroid Carcinoma Using High-Throughput Enhanced Quantitative Plasma Proteomics. Journal of Proteome Research. https://doi.org/10.1021/acs.jproteome.3c00187

Vancouver

Lu H, Pan Y, Ruan Y, Zhu C, Hassan HM, Gao J, et al. Biomarker Discovery for Early Diagnosis of Papillary Thyroid Carcinoma Using High-Throughput Enhanced Quantitative Plasma Proteomics. Journal of Proteome Research. 2023. doi:10.1021/acs.jproteome.3c00187

BibTeX
@article{Lu2023,
  author = {Lu, Hongsheng and Pan, Yin and Ruan, Yanyun and Zhu, Chumeng and Hassan, Hozeifa M and Gao, Junshun and Gao, Junli and Fan, Lilong and Liang, Xi and Wang, Hong and Ying, Shenpeng and Chen, Qi},
  title = {Biomarker Discovery for Early Diagnosis of Papillary Thyroid Carcinoma Using High-Throughput Enhanced Quantitative Plasma Proteomics},
  journal = {Journal of Proteome Research},
  year = {2023},
  doi = {10.1021/acs.jproteome.3c00187}
}
Kostenlos starten →